Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for Hyperlactatemia in Septic Shock
NCT03649009Unknown
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of thiamine in septic shock and hyperlactatemia (2 arms), sponsored by Hospital Canselor Tuanku Muhriz. Primary endpoint: Relative lactate level change from baseline to 24 hours. Status: unknown.
02
Drugs
thiamine
03
Conditions
septic shockhyperlactatemia
Beyond the preview
Go deeper on NCT03649009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03649009.